arginine vasopressin has been researched along with valsartan in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Alba, F; de Gasparo, M; Hermoso, F; Martínez, JM; Prieto, I; Ramírez, M; Ramírez, MJ; Vargas, F | 1 |
Bugaj, V; Kohan, DE; Mironova, E; Ramkumar, N; Rees, S; Roos, KP; Stockand, JD | 1 |
1 review(s) available for arginine vasopressin and valsartan
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for arginine vasopressin and valsartan
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effect of valsartan on angiotensin II- and vasopressin-degrading activities in the kidney of normotensive and hypertensive rats.
Topics: Aminopeptidases; Angiotensin II; Animals; Antihypertensive Agents; Arginine Vasopressin; Blood Pressure; Cystinyl Aminopeptidase; Drinking; Glutamyl Aminopeptidase; Hypertension, Renovascular; Kidney; Male; Placebos; Rats; Rats, Wistar; Tetrazoles; Valine; Valsartan | 2001 |
Adenylyl cyclase VI mediates vasopressin-stimulated ENaC activity.
Topics: Adenylyl Cyclases; Aldosterone; Animals; Antidiuretic Agents; Antihypertensive Agents; Aquaporin 2; Arginine Vasopressin; Blood Pressure; Epithelial Sodium Channels; Female; Heart Rate; Kidney Tubules, Collecting; Male; Mice; Mice, Knockout; Patch-Clamp Techniques; Renin; Sodium; Sodium Chloride, Dietary; Tetrazoles; Valine; Valsartan | 2013 |